Exploring the sulfate patterns of chondroitin sulfate/dermatan sulfate and keratan sulfate in human pancreatic cancer

J Pharm Biomed Anal. 2021 Oct 25:205:114339. doi: 10.1016/j.jpba.2021.114339. Epub 2021 Aug 26.

Abstract

This study was designed to explore the sulfation patterns of chondroitin sulfate (CS)/dermatan sulfate (DS), and keratan sulfate (KS) and the expression of carbohydrate sulfotransferases (CHSTs) in 26 pancreatic tumor and normal tissues. CS/DS and KS profiles were simultaneously determined. Pancreatic tumor tissues exhibited increased ΔDi-0S, ΔDi-4S, and ΔDi-6S levels, with absolute ΔDi-4S content being highest, followed by ΔDi-6S. However, as for the contents of KS-6S and KS-6S,6'S, there were no significant regular change. The expression levels of CHST1 and CHST4 were 37 and 15 times higher than those in normal tissues. PCA and OPLS-DA revealed that ΔDi-4S and ΔDi-6S levels could be reliably used to differentiate between healthy and cancerous tissues. The up-regulation of CHST3, CHST12, CHST13, and CHST15 was directly correlated with C-4 and C-6 sulfation. These data provide a foundation for future studies of the role of ΔDi-4S and ΔDi-6S in the progression of pancreatic cancer.

Keywords: Carbohydrate sulfotransferases; Chondroitin sulfate; Keratan sulfate; LC–MS/MS; Pancreatic cancer.

MeSH terms

  • Chondroitin Sulfates
  • Dermatan Sulfate
  • Humans
  • Keratan Sulfate*
  • Membrane Glycoproteins
  • Pancreatic Neoplasms*
  • Sulfates
  • Sulfotransferases / genetics

Substances

  • CHST15 protein, human
  • Membrane Glycoproteins
  • Sulfates
  • Dermatan Sulfate
  • Chondroitin Sulfates
  • Keratan Sulfate
  • Sulfotransferases